ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Luqing Tong(Johns Hopkins University), Xuejun Yang(Dali University), Michael Lim(Stanford University), Tianna Zhao(Leidos (United States)), Ravi Medikonda(Stanford University), Haiwen Ma(Ministry of Education of the People's Republic of China), John Choi(Stanford University), Jun Dong(TEDA International Cardiovascular Hospital), Jiabo Li(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Tao Li(Army Medical University), Xuya Wang(Tianjin Medical University General Hospital), Yi Li(Peking University), Yu Lin(Tianjin Medical University General Hospital), Peidong Liu(Johns Hopkins University), Yang Xie(Tianjin Medical University General Hospital), Shengping Yu(Tianjin Medical University General Hospital), Xun Jin(Tianjin Medical University Cancer Institute and Hospital), Qiuying Li(Nankai University), Qiang Huang(Ministry of Education of the People's Republic of China)
Cited by 162
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Geometric Interpretation of Gene Coexpression Network Analysis
|PLoS Computational Biology|2008|922
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650